Agatolimod (LIDDS)

N/A

Report date: 2025/04/24 17:01:17
NME

Base Information

Drug NameAgatolimod (LIDDS)
Drug Alias NameAgatolimod-NanoZolid formulatedNanoimodNanoZolid-TLR9 agonistNZ-TLR9NZ-IO-TLR9
ClassificationSmall molecules
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLidds Ab
China Registration ClassN/A

Develop Information

Active CompaniesLidds Ab
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A